Pancreatic steatosis in children. Part 2. Risk factors, diagnostic possibilitiess and therapy

Main Article Content

Yu.M. Stepanov
N.Yu. Zavgorodnyaya
N.Yu. Zavgorodnyaya


The article deals with the pancreatic steatosis in children — a pathological condition that is characterized by the accumulation of fat in the pancreas. The review presents data concerning risk factors, methods for diagnosis and treatment of pancreatic steatosis. The article demonstrates that the leading risk factors associated with pancreatic steatosis include obesity and metabolic syndrome. Diagnosis of pancreatic steatosis depends on non-invasive imaging techniques, such as transabdominal ultrasound, computed tomography, magnetic resonance imaging and endoscopic ultrasound. Therapy of pancreatic steatosis is based on lifestyle modification, therapy of dyslipidemia and carbohydrate metabolism disorders, correction of present exocrine insufficiency. To write a review, we used database Scopus, Web of Science, MedLine, PubMed, Google Scholar, CyberLeninka, RSCI with following keywords: “pancreatic steatosis”, “non-alcoholic fatty pancreas disease”, “children”.

Article Details

How to Cite
Stepanov, Y., Zavgorodnyaya, N., & Zavgorodnyaya, N. (2017). Pancreatic steatosis in children. Part 2. Risk factors, diagnostic possibilitiess and therapy. GASTROENTEROLOGY, 51(2), 144–151.
Reviews and Lections


Catanzaro R, Cuffari B, Italia A, Marotta F. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J Gastroenterol. 2016;22(34):7660-75. doi:10.3748/wjg.v22.i34.7660.

Samsonova NG, Zvenyhorodskaya LA. Clinical and functional state of pancreas in metabolic syndrome. EiKG. 2012;11:96-100.

Kim MK , Chun HJ , Park JH , et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabetes Res Clin Pract. 2014 Dec;106(3):590-6. doi: 10.1016/j.diabres.2014.09.005.

Rossi AP1, Fantin F, Zamboni GA, et al. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity (Silver Spring). 2011 Sep;19(9):1747-54. doi: 10.1038/oby.2011.114.

Sepe PS, Ohri A, Sanaka S, et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc. 2011 May;73(5):987-93. doi: 10.1016/j.gie.2011.01.015.

Wu WC, Wang C-Y. Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective study. Cardiovascular Diabetolog.  2013;12:77.  doi:10.1186/1475-2840-12-77.

Saisho Y, Butler A, Meier J, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20(8):933-42. doi: 10.1002/ca.20543.

Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15:1869-75. PMID: 19370785.

Kühn JP, Berthold F, Mayerle J, et al. Pancreatic Steatosis Demonstrated at MR Imaging in the General Population: Clinical Relevance. Radiology.  2015;276(1):129-136. doi: 10.1148/radiol.15140446.

Patel NS, Peterson MR, Lin GY, et al. Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterology Research and Practice. 2013;article ID 498296:8 pages. doi:10.1155/2013/498296.

Lingvay I, Esser V, Legendre JL, et al. Noninvasive Quantification of Pancreatic Fat in Humans. J Clin Endocrinol Metab. 2009;94(10):4070-6. doi:10.1210/jc.2009-0584.

Tariq H, Nayudu S, Akella S, et al. Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. Gastroenterology Res. 2016;9(6):87-91. doi: 10.14740/gr731w.

Zhou J, Li ML, Zhang DD, et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology. 2016 Jul-Aug;16(4):578-83. doi: 10.1016/j.pan.2016.03.008.

Yamazaki H, Tsuboya T, Katanuma A, et al. Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study. Diabetes Care. 2016;39(10):1677-83. doi: 10.2337/dc16-0074.

van Geenen EJ1, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, Mulder CJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas. 2010;39(8):1185-90. doi:10.1097/MPA.0b013e3181f6fce2.

Sijens PE, Edens MA, Bakker SJ, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol. 2010 Apr 28;16(16):1993-8. doi: 10.3748/wjg.v16.i16.1993.

Alempijevic T, Dragasevic S, Zec S, Popovic D, Milosavljevic T. Non-alcoholic fatty pancreas disease. Postgrad Med J. 2017 Apr;93(1098):226-230. doi: 10.1136/postgradmedj-2016-134546.

Aleshina EI, Novikova VP, Gurjeva VA, Burnysheva IA, Usychenko EA. Hepatic steatosis and fatty pancreas - 2 targets of metabolic syndrom in children. Experimental and Clinical Gastroenterology. 2014;8(108):16-20.

Pacifico L, Chiesa C. Pancreatic fat and hepato-metabolic features in obese children with nonalcoholic fatty liver disease. Clin Endocrinol. 2015;84(2):306-7. doi: 10.1111/cen.12870.

Lê KA, Ventura EE, Fisher JQ. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care. 2011;34(2):485–90. doi: 10.2337/dc10-0760 .

Cohen M, Syme C, Deforest M, et al. Ectopic fat in youth: the contribution of hepatic and pancreatic fat to metabolic disturbances. Obesity (Silver Spring). 2014;22(5):1280-6. doi: 10.1002/oby.20674.

Toledo-Corral CM, Alderete TL, Hu HH, et al. Ectopic fat deposition in prediabetic overweight and obese minority adolescents. J Clin Endocrinol Metab. 2013 Mar;98(3):1115-21. doi: 10.1210/jc.2012-3806.

Samsonova NG, Zvenyhorodskaya LA. Clinical and diagnostic features of steatosis of the pancreas in patients with the metabolic syndrome. Vestnik semeynoy meditsiny. 2015;1-2:30-6. (in Russian)

Prachayakul V, Aswakul P. Pancreatic Steatosis: What Should Gastroenterologists Know? J Pancreas. 2015:16(3): 227-231. doi: 10.6092/1590-8577/2987.

Nghiem DD, Olson PR, Ormond D. The "fatty pancreas allograft": anatomopathologic findings and clinical experience. Transplant Proc. 2004;36(4):1045-7. doi: 10.1016/j.transproceed.2004.04.032.

Ferrozzi F, Bova D, Campodonico F, et al. Cystic fibrosis: MR assessment of pancreatic damage. Radiology. 1996;198(3):875-9. doi: 10.1148/radiology.198.3.8628886.

Smits MM, Van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011;8:169-177. doi: 10.1038/nrgastro.2011.4.

Häring HU. Novel phenotypes of prediabetes? Diabetologia. 2016;59:1806-18. doi: 10.1007/s00125-016-4015-3.

Saisho Y. Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas. Rev Diabet Stud. 2016;13(2-3):132-147. doi: 10.1900/RDS.2016.13.132.

Smereczyński A, Kołaczyk K. Is a fatty pancreas a banal lesion? Journal of Ultrasonography. 2016;16(66):273-280. doi:10.15557/JoU.2016.0027.

Stepanov YM, Gravirovskaya NG. The first results of the application of transient sharewave elastometry in determining the state of pancreatic parenchyma (literature review and own research). Hastroenterolohiya. 2015;57:53-59. doi: 10.22141/2308-2097.3.57.2015.81527.

Barr RG. Elastography in Clinical Practice. Radiol Clin North Am. 2014 Nov;52(6):1145-62. doi: 10.1016/j.rcl.2014.07.002.

de Oliveira Andrade LJ, Guimarães LR, et al. Pancreatic steatosis and its association with nonalcoholic fatty liver disease evaluated by ultrasonography. Brazilian Journal of Medicine and Human Health. 2015;3(2):37-43. doi: 10.17267/2317-3386bjmhh.v3i2.653.

Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care. 2007;30(11):291629-21. doi: 10.2337/dc07-0326.

Matsumoto S, Mori H, Miyake H, et al. Uneven fatty replacement of the pancreas: evaluation with CT. Radiology. 1995;194(2):453-8. doi: 10.1148/radiology.194.2.7824726.

Pham YH, Bingham BA, Bell CS, et al. Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center. South Med J. 2016;109(3):196-8. doi: 10.14423/SMJ.0000000000000432.

Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;37(6):630-9. doi: 10.1111/apt.12237.

Nakajima K, Nemoto T, Muneyuki T, Kakei M, Fuchigami H, Munakata H. Low serum amylase in association with metabolic syndrome and diabetes: A community-based study. Cardiovasc Diabetol. 2011 Apr 17;10:34. doi: 10.1186/1475-2840-10-34.

Rossi AP, Fantin F, Zamboni GA, et al. Effect of moderate weight loss on hepatic, pancreatic and visceral lipids in obese subjects. Nutr Diabetes. 2012 Mar; 2(3): e32. doi:10.1038/nutd.2012.5.

Jia DM, Fukumitsu KI, Tabaru A, Akiyama T, Otsuki M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am J Physiol Regul Integr Comp Physiol. 2001; 280(5): 1332-40.

Souza-Mello V, Gregorio B, Relvas-Lucas B, et al. Pancreatic Ultrastructural Enhancement Due to Telmisartan Plus Sitagliptin Treatment in Diet-Induced Obese C57BL/6 Mice. Pancreas. 2011;40(5):715-22. doi: 10.1097/MPA.0b013e3182153922.

Miyazaki M, Kato M, Tanaka K, et al. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep. 2012; 5(3):729-33. doi: 10.3892/mmr.2011.707.

Yang W, Gao J, Tai Y, et al. Betaine Attenuates Alcohol-Induced Pancreatic Steatosis. Pancreas. 2016 Jul;45(6):836-45. doi: 10.1097/MPA.0000000000000557.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>